GADD45GIP1 and inflammatory bowel disease: To investigate the effect of CRIF1 overexpression on the development of IBD, p3XFLAG-CMV-10-CRIF1 was intravenously injected 1 day before and on day 7 from the start of 3% DSS treatment, and the efficacy of CRIF1 was evaluated.